Are muscle relaxants safe to use with fluoxetine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Muscle Relaxants Can Generally Be Used With Fluoxetine, But Cyclobenzaprine Requires Caution

Most muscle relaxants (methocarbamol, metaxalone, orphenadrine, tizanidine) can be safely combined with fluoxetine, but cyclobenzaprine should be avoided or used with extreme caution due to its structural similarity to tricyclic antidepressants and potential for serotonin syndrome.

Key Safety Considerations

High-Risk Combination: Cyclobenzaprine + Fluoxetine

Cyclobenzaprine is structurally related to amitriptyline (a tricyclic antidepressant) and acts as a 5-HT2 receptor antagonist 1. Concomitant use of cyclobenzaprine with monoamine oxidase inhibitors may increase the potential for serotonin syndrome 1. While fluoxetine is an SSRI (not an MAOI), the guideline explicitly warns about combining serotonergic medications 2.

The 2020 AACAP guideline states that caution should be exercised when combining two or more non-MAOI serotonergic drugs, and this entails starting the second drug at a low dose, increasing slowly, and monitoring for symptoms especially in the first 24-48 hours 2. Given cyclobenzaprine's tricyclic structure and serotonergic effects, this represents a potentially problematic combination.

Lower-Risk Muscle Relaxants

The following muscle relaxants have no documented serotonergic interactions and can be used more safely with fluoxetine:

  • Methocarbamol: Centrally acting without direct skeletal muscle effects; main concerns are drowsiness, dizziness, and cardiovascular effects (bradycardia, hypotension) 1
  • Metaxalone: Centrally acting with CNS side effects (drowsiness, dizziness, irritability) but no serotonergic interactions noted 1
  • Orphenadrine: Has anticholinergic properties but no documented serotonergic risk 1
  • Tizanidine: Can be taken preoperatively including day of surgery per guidelines, suggesting acceptable safety profile 1

Carisoprodol Considerations

Carisoprodol has significant abuse potential and is classified as a controlled substance 1. While no specific serotonergic interaction with fluoxetine is documented, its barbiturate-like effects and high abuse potential make it a less favorable choice regardless of fluoxetine use 1.

Serotonin Syndrome Warning Signs

When combining any potentially serotonergic medications with fluoxetine, monitor for 2:

  • Mental status changes: Confusion, agitation, anxiety
  • Neuromuscular hyperactivity: Tremors, clonus, hyperreflexia, muscle rigidity
  • Autonomic hyperactivity: Hypertension, tachycardia, arrhythmias, diaphoresis, shivering
  • Advanced symptoms: Fever, seizures, unconsciousness (can be fatal)

Symptoms typically arise within 24-48 hours after combining medications 2.

Practical Prescribing Algorithm

  1. If muscle relaxant needed with fluoxetine:

    • First choice: Methocarbamol, metaxalone, or tizanidine
    • Avoid: Cyclobenzaprine (due to serotonergic risk)
    • Use cautiously: Carisoprodol (abuse potential, not serotonergic concern)

  2. If patient already on cyclobenzaprine:

    • Consider switching to alternative muscle relaxant before starting fluoxetine
    • If must continue both, start at lowest dose and monitor intensively for 24-48 hours after any dose changes
    • Educate patient on serotonin syndrome symptoms

  3. Monitor all combinations for:

    • Additive CNS depression (sedation, dizziness)
    • Serotonin syndrome symptoms (first 48 hours critical)
    • Fall risk, especially in elderly patients 3

Additional Drug Interaction Considerations

Fluoxetine is a potent CYP2D6 inhibitor and has a very long half-life (5 weeks for complete elimination) 4. This can affect metabolism of other medications, but muscle relaxants are not primarily metabolized by CYP2D6, so this interaction is less relevant for this drug class.

The FDA label explicitly contraindicates fluoxetine with MAOIs and requires at least 5 weeks after stopping fluoxetine before starting an MAOI 4. While muscle relaxants are not MAOIs, the cyclobenzaprine warning about MAOI combinations suggests similar caution with serotonergic antidepressants 1.

Common Pitfalls to Avoid

  • Don't assume all muscle relaxants are equivalent: Cyclobenzaprine has unique serotonergic properties that distinguish it from other muscle relaxants
  • Don't overlook structural similarities: Cyclobenzaprine's tricyclic structure makes it pharmacologically distinct despite being classified as a "muscle relaxant"
  • Don't forget fluoxetine's long half-life: Effects and interactions can persist for 5+ weeks after discontinuation 4
  • Don't ignore additive sedation: Even without serotonergic risk, combining CNS depressants increases fall risk and impairment 3

References

2
Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

3
Guideline

pharmacological management of persistent pain in older persons.

Journal of the American Geriatrics Society (JAGS), 2009

Related Questions

In otherwise healthy adults with acute muscle spasm, which is the more effective muscle relaxant: cyclobenzaprine (Flexeril) or methocarbamol?
What muscle relaxant is safe to prescribe for a patient receiving antiseizure medication?
Can carisoprodol (Soma) be taken concurrently with cyclobenzaprine?
Is it safe for a 36-year-old male to take fluoxetine 40 mg daily together with mirtazapine 7.5 mg daily?
A male in his 30s has been taking Prozac (fluoxetine) 10 mg daily for about five months and now reports worsening insomnia, dry mouth, nausea, and a strange sensation in his ears when speaking that affects his ability to speak; he wishes to discontinue the medication—what is the best way to taper fluoxetine?
Is it appropriate to give a 10 mg intravenous dose of midazolam?
In a patient with small intestinal bacterial overgrowth on a low‑FODMAP diet, are olive oil and avocado oil appropriate for cooking, and can olive oil with apple cider vinegar be used safely in a salad dressing?
For a patient with small‑intestinal bacterial overgrowth on a low‑FODMAP diet, is a combined fish‑oil supplement containing vitamin D3 appropriate, and can small portions of cauliflower, broccoli, or asparagus be safely included?
What are the appropriate indications, treatment regimen, and contraindications for hyperbaric oxygen therapy?
Can sumatriptan be used concurrently with minoxidil?
How frequently does necrosis occur in untreated breast cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.